Shimada Mikio, Dumitrache Lavinia C, Russell Helen R, McKinnon Peter J
Department of Genetics, St Jude Children's Research Hospital, Memphis, TN, USA.
Department of Genetics, St Jude Children's Research Hospital, Memphis, TN, USA
EMBO J. 2015 Oct 1;34(19):2465-80. doi: 10.15252/embj.201591363. Epub 2015 Aug 19.
Polynucleotide kinase-phosphatase (PNKP) is a DNA repair factor possessing both 5'-kinase and 3'-phosphatase activities to modify ends of a DNA break prior to ligation. Recently, decreased PNKP levels were identified as the cause of severe neuropathology present in the human microcephaly with seizures (MCSZ) syndrome. Utilizing novel murine Pnkp alleles that attenuate expression and a T424GfsX48 frame-shift allele identified in MCSZ individuals, we determined how PNKP inactivation impacts neurogenesis. Mice with PNKP inactivation in neural progenitors manifest neurodevelopmental abnormalities and postnatal death. This severe phenotype involved defective base excision repair and non-homologous end-joining, pathways required for repair of both DNA single- and double-strand breaks. Although mice homozygous for the T424GfsX48 allele were lethal embryonically, attenuated PNKP levels (akin to MCSZ) showed general neurodevelopmental defects, including microcephaly, indicating a critical developmental PNKP threshold. Directed postnatal neural inactivation of PNKP affected specific subpopulations including oligodendrocytes, indicating a broad requirement for genome maintenance, both during and after neurogenesis. These data illuminate the basis for selective neural vulnerability in DNA repair deficiency disease.
多核苷酸激酶-磷酸酶(PNKP)是一种DNA修复因子,具有5'-激酶和3'-磷酸酶活性,可在连接之前修饰DNA断裂的末端。最近,PNKP水平降低被确定为患有癫痫的人类小头畸形(MCSZ)综合征中严重神经病理学的原因。利用可减弱表达的新型小鼠Pnkp等位基因以及在MCSZ个体中鉴定出的T424GfsX48移码等位基因,我们确定了PNKP失活如何影响神经发生。神经祖细胞中PNKP失活的小鼠表现出神经发育异常和出生后死亡。这种严重的表型涉及碱基切除修复缺陷和非同源末端连接,这是修复DNA单链和双链断裂所需的途径。尽管T424GfsX48等位基因纯合的小鼠在胚胎期致死,但PNKP水平降低(类似于MCSZ)表现出一般的神经发育缺陷,包括小头畸形,表明存在关键的发育性PNKP阈值。出生后对PNKP进行定向神经失活会影响包括少突胶质细胞在内的特定亚群,这表明在神经发生期间和之后对基因组维持都有广泛需求。这些数据阐明了DNA修复缺陷疾病中选择性神经易损性的基础。